Effect of combination inhaled therapy on ventilation distribution measured by SPECT/CT imaging in uncontrolled asthma
…, DL Bailey, M Trifunovic… - Journal of Applied …, 2021 - journals.physiology.org
Asthma is characterized by heterogeneous ventilation as measured by three-dimensional
ventilation imaging. Combination inhaled corticosteroid/long-acting β 2 -agonist (ICS/LABA) …
ventilation imaging. Combination inhaled corticosteroid/long-acting β 2 -agonist (ICS/LABA) …
Risk stratification in heart failure using 123I-MIBG
Heart failure is a progressive, heterogeneous form of cardiovascular disease that requires
treatment to be individualized depending on the presenting symptoms. A decision to use an …
treatment to be individualized depending on the presenting symptoms. A decision to use an …
[HTML][HTML] Safety and tolerability of Miltuximab®-a first in human study in patients with advanced solid cancers
…, S Wissmueller, H Mazure, M Trifunovic… - Asia Oceania Journal …, 2021 - ncbi.nlm.nih.gov
Objective (s): Miltuximab® is a chimeric antibody targeting Glypican-1 (GPC-1), a cell surface
antigen which is overexpressed in solid cancers. Miltuximab® has shown promising safety …
antigen which is overexpressed in solid cancers. Miltuximab® has shown promising safety …
Pituitary incidentaloma found on O-(2-18F-fluoroethyl)-l-tyrosine PET
Although incidental pituitary findings on 18 F-FDG PET are uncommon, there are several
reports published in the literature. It is believed that this is the first reporting of incidental …
reports published in the literature. It is believed that this is the first reporting of incidental …
Outcomes of the miltuximab first in human trial and proposed study design for a phase I trial 89Zr/177Lu theranostic trial.
261 Background: Miltuximab is a chimeric antibody targeting Glypican-1 which is
overexpressed in prostate cancer. Miltuximab has shown promising safety and efficacy in …
overexpressed in prostate cancer. Miltuximab has shown promising safety and efficacy in …
18F-DCFPyL PET/CT in metastatic renal cell carcinoma
GM Currie, M Trifunovic, J Liu, S Kim… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Targeted molecular imaging with PET uses chemical ligands that are peptides specifically
targeting a receptor of interest. Prostate-specific membrane antigen (PSMA) is substantially …
targeting a receptor of interest. Prostate-specific membrane antigen (PSMA) is substantially …
[PDF][PDF] RISK STRATIFICATION IN HEART FAILURE USING 123I-mIBG.
M Trifunovic, G Currie - researchgate.net
Heart failure (HF) is a progressive, heterogeneous form of cardiovascular disease that requires
treatment to be individualised depending on the presenting symptoms. A decision to use …
treatment to be individualised depending on the presenting symptoms. A decision to use …
PET/CT/MRI Fusion in the central nervous system.
M Trifunovic, J Magnussen, C Saunders - Gamma Gazette, 2011 - search.ebscohost.com
The article presents two case studies in which both patients have a lesion in their pons. It
mentions that the first patient was 19-year-old female with history of ammenorhoea for eight …
mentions that the first patient was 19-year-old female with history of ammenorhoea for eight …
POLARIS: the distributed SQL engine in azure synapse
…, A Tomic, D Tomic, S Toscano, D Trifunovic… - Proceedings of the …, 2020 - dl.acm.org
In this paper, we describe the Polaris distributed SQL query engine in Azure Synapse. It is the
result of a multi-year project to re-architect the query processing framework in the SQL DW …
result of a multi-year project to re-architect the query processing framework in the SQL DW …
Ambient temperature and cardiac accumulation of FDG
2533 Objectives Warming patients by changing the ambient environment (rather than core
temperature) has been reported to successfully reduce BAT activity, however, a reduction of …
temperature) has been reported to successfully reduce BAT activity, however, a reduction of …